Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Maria A. Sullivan, MD, PhD
Alkermes, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- North Country Clinical Research
Oceanside, California, United States
- Nrc Research Institute
Orange, California, United States
- Atlantic Shores Hospital
Lauderhill, Florida, United States
- Try Research
Maitland, Florida, United States
- Research Centers of America
Oakland Park, Florida, United States
- Cns Healthcare
Orlando, Florida, United States
- Neuroscience Research Institute
Winfield, Illinois, United States
- John Hopkins University School of Medicine
Baltimore, Maryland, United States
- Comprehensive Clinical Research
Berlin, New Jersey, United States
- Pra Health Sciences
Marlton, New Jersey, United States
- New York State Psychiatric Institute/ Columbia University
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Neuro-Behavioral Clinical Research, Inc.
Canton, Ohio, United States
- Midwest Clinical Research Center, Llc
Dayton, Ohio, United States
- University of Pennsylvania - Treatment Research Center
Philadelphia, Pennsylvania, United States
- Western Psychiatric Institute and Clinic of Upmc
Pittsburgh, Pennsylvania, United States
- Community Clinical Research, Inc.
Austin, Texas, United States
- Insite Clinical Research
DeSoto, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Pharmaceutical Research Associates Inc.
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2015
- Primary completion
- 27 Oct 2016
- Completion
- 9 Jan 2017
- Last update posted
- 6 Mar 2019
- Registered enrollment
- 380
- Registry id
- NCT02537574
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.